BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33437389)

  • 1. SOX12 expression is associated with progression and poor prognosis in human breast cancer.
    Xu J; Zhang J; Li L; Mao J; You T; Li Y
    Am J Transl Res; 2020; 12(12):8162-8174. PubMed ID: 33437389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
    Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
    Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
    Du F; Feng W; Chen S; Wu S; Cao T; Yuan T; Tian D; Nie Y; Wu K; Fan D; Xia L
    Cancer Lett; 2019 Jun; 452():103-118. PubMed ID: 30922917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of transcription factor SOX12 in lung adenocarcinoma and its clinical significance].
    Li L; Zhang T; Chen Y; Song J; Meng Y; Liu S; Xie J
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):186-191. PubMed ID: 30890507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the m
    Li Y; Cao J; Wang J; Wu W; Jiang L; Sun X
    Cancer; 2024 Feb; 130(3):356-374. PubMed ID: 37861451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.
    Wang L; Hu F; Shen S; Xiao H; Li G; Wang M; Mei J
    Am J Transl Res; 2017; 9(9):4003-4014. PubMed ID: 28979676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low SOX12 Expression Is Correlated With Poor Prognosis in Patients With Gastric Cancer.
    Yang KK; Xu HM; Huang JY; Guo YX; Wang ZN
    Technol Cancer Res Treat; 2020; 19():1533033819901126. PubMed ID: 32019439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis.
    Du F; Chen J; Liu H; Cai Y; Cao T; Han W; Yi X; Qian M; Tian D; Nie Y; Wu K; Fan D; Xia L
    Cell Death Dis; 2019 Mar; 10(3):239. PubMed ID: 30858360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
    Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D
    Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting
    Jiang T; Guan LY; Ye YS; Liu HY; Li R
    Am J Cancer Res; 2017; 7(6):1310-1321. PubMed ID: 28670493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer.
    Hong C; Li T; Zhang F; Wu X; Chen X; Cui X; Zhang G; Cui Y
    Oncol Lett; 2017 Nov; 14(5):5379-5385. PubMed ID: 29113172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression.
    Yuan P; Meng L; Wang N
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3821-3826. PubMed ID: 28975985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells.
    Ding H; Quan H; Yan W; Han J
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27582508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
    Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
    Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.